A phase I study of the PARP inhibitor niraparib in combination with bevacizumab in platinum-sensitive epithelial ovarian cancer: NSGO AVANOVA1/ENGOT-OV24
| Image |  |
|---|---|
| Description | scientific article published on 02 August 2019 |
| Author/s |
author: Kim Brosen Mansoor Raza Mirza Troels K Bergmann Morten Mau-Sorensen Flemming Nielsen |
| Publication date | August 2, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |